Most-Favored Nation Drug Pricing Could Shake Up US Pharma
As part of a broader resurgence in pharmaceutical pricing reform and manufacturing policies in 2025, President Donald Trump and bipartisan congressional leaders have introduced contemporaneous proposals to lower prescription drug prices...To view the full article, register now.
Already a subscriber? Click here to view full article